| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |